There is a lot of energy around educating consumers about their risk for type 2 diabetes, explained Brenda Schmidt, CEO of Solera Health.
There is a lot of energy around educating consumers about their risk for type 2 diabetes, explained Brenda Schmidt, CEO of Solera Health.
Transcript
What is the partnership Solera Health has with the American Diabetes Association to help people with prediabetes find a Diabetes Prevention Program (DPP) provider?
Solera’s really excited about our partnership with the American Diabetes Association, and what we recognized is that there was a lot of energy around educating consumers around their risk for type 2 diabetes and there was a program available to them to reduce their risk and improve their health. But, what we also noticed was that there wasn’t an efficient way for people to identify where a high-quality, local community DPP provider was, and whether they were covered by their insurance.
So, the partnership with the American Diabetes Association allows those people who are identified as high-risk for type 2 diabetes through the American Diabetes Association’s screener to be sent over to Solera for us to actually find a program for them that best meets their unique needs and preferences, verify their eligibility, and enroll them in a program so they can get started on improving their health.
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen